Annovis Bio, Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Annovis Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Annovis Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$8.25M, a 5726% decline year-over-year.
  • Annovis Bio, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$10.5M, a 1659% decline year-over-year.
  • Annovis Bio, Inc. annual Nonoperating Income (Expense) for 2023 was -$11.2M, a 6213% decline from 2022.
  • Annovis Bio, Inc. annual Nonoperating Income (Expense) for 2022 was $183K, a 265% increase from 2021.
  • Annovis Bio, Inc. annual Nonoperating Income (Expense) for 2021 was $50.1K, a 95.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$11.2M -$11.4M -6213% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $183K +$133K +265% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $50.1K -$1.13M -95.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $1.18M +$564K +91.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $615K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.